ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

PMVP PMV Pharmaceuticals Inc

2.13
-0.08 (-3.62%)
21 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PMV Pharmaceuticals Inc PMVP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.08 -3.62% 2.13 15:07:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.20 2.11 2.20 2.13 2.21
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202407:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202407:00EDGAR2Form 8-K - Current report
09/5/202407:00GLOBEPMV Pharmaceuticals Reports First Quarter 2024 Financial..
27/3/202407:00GLOBEPMV Pharmaceuticals Announces First Patient Dosed in Global..
18/3/202415:01GLOBEPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in..
29/2/202415:05EDGAR2Form 8-K - Current report
29/2/202415:01GLOBEPMV Pharmaceuticals Reports Full Year 2023 Financial Results..
26/2/202407:00GLOBEPMV Pharmaceuticals to Participate in the TD Cowen 44th..
24/1/202408:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:02EDGAR2Form 8-K - Current report
18/1/202415:01GLOBEPMV Pharmaceuticals Announces Prioritization of PC14586..
11/1/202415:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202415:01EDGAR2Form 8-K - Current report
05/1/202415:01GLOBEPMV Pharmaceuticals Strengthens Leadership with Key..
09/11/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202307:00EDGAR2Form 8-K - Current report
09/11/202307:00GLOBEPMV Pharmaceuticals Reports Third Quarter 2023 Financial..
12/10/202316:02EDGAR2Form 8-K - Current report
12/10/202311:30GLOBEPMV Pharmaceuticals Updated PC14586 Phase 1 Data..
11/10/202315:02EDGAR2Form 8-K - Current report
11/10/202311:00GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
20/9/202315:05GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
18/9/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202307:00EDGAR2Form 8-K - Current report
09/8/202307:00GLOBEPMV Pharmaceuticals Reports Second Quarter 2023 Financial..
06/6/202315:01GLOBEPMV Pharmaceuticals to Participate in the Goldman Sachs..

Su Consulta Reciente

Delayed Upgrade Clock